- Report
- June 2026
- 200 Pages
Europe
From €2686EUR$2,990USD£2,301GBP
- Report
- April 2026
- 200 Pages
United States
From €2686EUR$2,990USD£2,301GBP
- Report
- April 2026
- 100 Pages
United States
From €3548EUR$3,950USD£3,039GBP
- Report
- September 2025
- 85 Pages
United States
From €3144EUR$3,500USD£2,693GBP
- Report
- April 2026
- 75 Pages
United States
From €4267EUR$4,750USD£3,655GBP
- Report
- January 2026
- 68 Pages
North America
From €4267EUR$4,750USD£3,655GBP
- Report
- February 2026
- 150 Pages
United States
From €4357EUR$4,850USD£3,732GBP
- Report
- October 2025
- 86 Pages
United States
From €4043EUR$4,500USD£3,463GBP
- Report
- February 2024
- 135 Pages
Asia Pacific
From €2650EUR$2,950USD£2,270GBP
- Report
- December 2023
- 133 Pages
Europe
From €1325EUR$1,475USD£1,135GBP
€2650EUR$2,950USD£2,270GBP
- Report
- August 2023
- 338 Pages
Global
From €2470EUR$2,750USD£2,116GBP
€4941EUR$5,500USD£4,232GBP
- Report
- March 2024
- 247 Pages
Global
From €3751EUR$4,175USD£3,213GBP
- Report
- May 2025
- 251 Pages
Global
From €4447EUR$4,950USD£3,809GBP
- Report
- January 2025
- 429 Pages
Global
From €4447EUR$4,950USD£3,809GBP
- Report
- March 2025
- 149 Pages
Global
From €3144EUR$3,500USD£2,693GBP
- Report
- January 2023
- 280 Pages
Global
From €3773EUR$4,200USD£3,232GBP
- Report
- February 2022
- 361 Pages
Global
From €3369EUR$3,750USD£2,886GBP
- Report
- November 2020
- 298 Pages
Global
From €3144EUR$3,500USD£2,693GBP
- Report
- July 2024
- 200 Pages
Global
From €2057EUR$2,290USD£1,762GBP
- Report
- July 2025
- 200 Pages
Australia
From €2237EUR$2,490USD£1,916GBP

The Cardiac Monitoring market is a segment of the Cardiovascular Devices industry that focuses on the diagnosis and treatment of heart-related conditions. It includes a range of products such as electrocardiographs (ECGs), Holter monitors, event recorders, and implantable loop recorders. These devices are used to measure and monitor the electrical activity of the heart, detect arrhythmias, and diagnose heart conditions.
Cardiac Monitoring devices are used in both inpatient and outpatient settings, and are often used in conjunction with other cardiovascular treatments such as pacemakers and defibrillators. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for remote patient monitoring.
Notable companies in the Cardiac Monitoring market include Abbott, Biotronik, Boston Scientific, GE Healthcare, Medtronic, Philips, and Siemens Healthineers. Show Less Read more